RxDoctor Payments Data

Stephanie Peterson

Psychiatric/Mental Health · Redding, CANPI 1780854760

Payments from drug & device makers

$2,879in general payments, 2019–2025

Across 137 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • AbbVie$735
  • Otsuka America Pharmaceutical, Inc.$212
  • Boston Scientific$204
  • Alkermes, Inc.$134
  • Teva Pharmaceuticals USA, Inc.$95
  • plus $423 from 8 others

What the payments were for

  • Food & beverage$2,81898%
  • Education$612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,879 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole13$18,822
Duloxetine Hcl52$509
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$342
Venlafaxine Hcl ErVenlafaxine Hcl41$252
Fluoxetine Hcl16$203
Escitalopram Oxalate21$111
Quetiapine Fumarate17$90
Clonidine Hcl26$87
Mirtazapine19$84
Lorazepam14$60
Risperidone11$41
Citalopram HbrCitalopram Hydrobromide13$5

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$212$18,82213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Redding

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →